Toujeo Insulin Glargine 300Iu/Ml 1X3's

long-acting insulin (up to 6 hours)

DRUG INTERACTIONS: - Certain drugs may affect glucose metabolism, requiring insulin dose adjustment and close monitoring of blood glucose. The signs of hypoglycemia may be reduced in patients taking anti-adrenergic drugs (e.g., beta-blockers, clonidine, guanethidine, and reserpine). ADVERSE REACTIONS: - Adverse reactions commonly associated with Toujeo include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema and weight gain. CONTRAINDICATIONS: - Toujeo is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin glargine or any of its excipients.

Turn the dose selector until it lines up with your dose. If you turn past it, turn back. Make sure the window shows your prescribed dose.
Keeping the pen straight, push the needle into your skin, and then press the button all the way in with your thumb and hold. Try not to press at an angle; you don't want your thumb to block the dose selector from turning.
When you see 0 in the dose window, slowly count to 5 to ensure you have the full dose. Then release the injection button and remove the needle from your skin

Ingredients

Insulin Glargine 300IU

Indication

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Route Of Administration

Subcutaneous

Suitable For

Adults

Gender

Unisex

Formulation

Injections

Storage Temperature

2-8°C

Country Of Origin

Germany